Fact-checked by Grok 2 weeks ago

Vacutainer

A Vacutainer is a trademarked brand of evacuated blood collection tubes and associated systems manufactured by Becton, Dickinson and Company (BD), designed for the safe and efficient collection of venous blood specimens in clinical and laboratory settings. These sterile tubes, typically made of glass or plastic with colored rubber stoppers that maintain a partial vacuum, enable blood to flow directly into the tube when connected to a needle and holder, minimizing exposure to air and reducing contamination risks during phlebotomy. Invented in 1949 by Joseph Kleiner, the Vacutainer revolutionized blood sampling by replacing open syringe methods with a closed, single-use system that improves specimen integrity and supports accurate diagnostic testing. The Vacutainer system encompasses a range of components, including various types differentiated by color-coded stoppers that indicate additives such as anticoagulants (e.g., EDTA for tests or for chemistry analyses) or clot activators for separation, ensuring compatibility with specific assays. Key features include safety mechanisms like push-button blood collection sets that reduce needlestick injuries by up to 88% and luer-lok access devices that decrease rupture—by 83%, thereby enhancing sample quality and patient safety. Widely adopted in healthcare worldwide since its introduction, the system has become a standard for routine blood draws, contributing to reliable results in diagnostics for conditions ranging from to infectious diseases.

Design and Principles

Basic Components

Vacutainer tubes are primarily constructed from (PET) plastic or , with PET offering advantages such as break resistance, lighter weight, and reduced risk of specimen spillage during handling and transport. In contrast, provides greater chemical inertness, making it suitable for specific tests requiring minimal interference, such as trace element analysis. The core structural elements include a cylindrical body that maintains the tube's vacuum-sealed interior for controlled blood draw, topped with a rubber stopper lubricated with or glycerin to facilitate needle penetration and minimize sample . Many tubes feature a BD Hemogard™ closure, incorporating a or that recesses the rubber stopper to enhance by preventing contact with blood droplets on the rim. The interior walls are often silicone-coated to reduce red blood cell adherence and promote smoother flow. Standard Vacutainer tubes come in sizes ranging from 13 × 75 mm to 16 × 100 mm, with draw volumes typically between 2 mL and 10 mL to accommodate various collection needs. Labeling on the tubes and includes spaces for information, such as name and date of collection, along with indicators for additive type to ensure proper identification and use. The closure system is designed for compatibility with multi-sample luer adapters, featuring a male slip-luer fitting that securely attaches to needle holders or blood collection sets for efficient, sterile sampling.

Operational Mechanism

The Vacutainer system relies on a principle to facilitate efficient and sterile collection. During manufacturing, air is evacuated from the tube, creating a partial sealed by a rubber stopper, which generates relative to . When the needle pierces a and the tube's stopper, the pressure differential draws into the tube until the equalizes or the predetermined is reached, minimizing the need for manual aspiration and reducing discomfort. This mechanism ensures a that limits exposure to contaminants. Blood flow dynamics in the Vacutainer are governed by the pressure differential between and the tube's internal vacuum, denoted as ΔP = P_atm - P_vacuum, where blood flow rate is approximately proportional to ΔP (flow rate ≈ k * ΔP, with k as a tube-specific constant incorporating factors like and ). The vacuum strength is calibrated to control the fill volume precisely, typically drawing 2-10 mL of depending on tube size, which prevents overfilling that could lead to from excessive or underfilling that might compromise sample quality. Flow ceases automatically once is achieved, allowing sequential changes without re-puncturing the . The system interacts with multi-sample needles or blood collection sets featuring a double-ended hypodermic needle, typically 20-25 gauge and 1-1.5 inches long, where one end enters the and the other pierces the stopper to activate the . Compatibility extends to safety-engineered devices, such as push-button or sets, which incorporate mechanisms like retractable needles or shielding to reduce risks during or disposal. These designs maintain the integrity of the while enabling safe handling. In terms of preservation, the vacuum minimizes air entry into the , which could introduce bubbles or oxygen that promote clotting or cellular , while the immediate influx of allows for rapid mixing with any included preservatives upon inversion of the tube. This combination sustains sample viability for downstream analysis, such as or tests, by stabilizing cellular components and analytes until laboratory processing.

Tube Types and Additives

Color-Coding System

The color-coding system for Vacutainer tubes uses standardized stopper colors to quickly identify the type of additive or intended use, facilitating efficient blood collection and processing in clinical settings. This system adheres to the (ISO) 6710:2017, which specifies closure colors for single-use containers for specimen collection to promote global harmonization and reduce errors in laboratory workflows. While ISO 6710 provides an international framework, regional variations exist, such as those outlined by the Clinical and Laboratory Standards Institute (CLSI) in the United States, which may differ slightly in color assignments for certain additives to align with local practices. For instance, both standards designate purple stoppers for tubes containing EDTA as an anticoagulant for whole blood hematology tests, light blue for in studies, and green for or sodium in chemistry applications; however, in practice, yellow stoppers often indicate tubes with sodium polyanetholsulfonate () for (as in Vacutainer systems), whereas ISO 6710:2017 designates yellow for ACD or CPDA additives used in blood banking; CLSI equivalents might use similar hues but emphasize compatibility with automated systems. Despite efforts toward global standardization via ISO 6710:2017, some variations persist between standards and manufacturer implementations, particularly for specialized tubes like . The color-coding system has evolved since the introduction of Vacutainer tubes in the , initially featuring simple black or white rubber stoppers without distinct hues, to the multi-colored or closures developed by Becton Dickinson in the for differentiation by additive type.
Stopper ColorCommon AdditiveTypical UseStandard Fill Volume (mL)
Purple (Lavender)K2EDTA (e.g., )2–4
Red or Gold ()Clot activator ± gel chemistry5–10
Light Blue3.2% (e.g., PT/PTT)2–4.5
GreenLithium or Sodium chemistry3–5
YellowSPS or ACD or DNA5–8
Gray + Glucose testing2–4
These colors are printed on tube labels for redundancy, with many contemporary Vacutainer models integrating barcodes or RFID tags for automated scanning and tracking in systems, minimizing manual errors and supporting from collection to .

Specific Additives and Applications

Vacutainer tubes incorporate various chemical additives tailored to preserve blood samples for specific analyses, ensuring the integrity of cellular components, , or as required by the test. These additives prevent clotting, inhibit metabolic processes, or accelerate , with formulations standardized to maintain consistent blood-to-additive ratios for accurate results. Anticoagulants are essential for tests requiring or . EDTA, typically in the form of K2EDTA (dipotassium ) at a concentration of 1.8 mg/mL, binds calcium ions to inhibit the clotting cascade, preserving cell morphology for applications such as complete blood counts () and blood typing. Na2EDTA (disodium ) serves similar purposes but is less commonly used due to potential sodium interference in certain assays. , provided as a 3.2% buffered solution (0.109 M), maintains a 9:1 blood-to-citrate ratio to chelate calcium reversibly, enabling studies like (PT) and (PTT). Heparin functions as another by inhibiting and other clotting factors, producing suitable for rapid chemistry testing, particularly electrolytes and enzymes where sodium interference must be minimized; heparin is preferred over for this reason. For glucose preservation, (NaF) combined with potassium (KOx), often at 10 mg NaF and 8 mg KOx per tube, inhibits by blocking while the anticoagulates, preventing glucose metabolism for up to 24 hours post-collection. Clot activators facilitate serum separation for chemistry panels. Micronized silica particles, spray-coated inside tubes, activate the intrinsic coagulation pathway, promoting clot formation in 30-60 minutes for general serum chemistry and therapeutic drug monitoring. Thrombin-based activators in specialized tubes accelerate clotting to 5 minutes, ideal for stat serum determinations in urgent settings. Specialized tubes address niche applications. Royal blue tubes omit metal-containing additives, using either no additive or minimal EDTA to avoid contamination in trace element analysis (e.g., lead, mercury) via inductively coupled plasma mass spectrometry. Black tubes contain a higher concentration of (e.g., 3.8% or 0.105 M), achieving a 4:1 blood-to-citrate ratio to standardize (ESR) testing for inflammation assessment, compatible with automated analyzers. In , tubes with sodium polyanethol sulfonate (SPS) preserve for culture; for , EDTA or specialized stabilizers maintain nucleic acids for PCR-based tests like viral detection, ensuring compatibility with automated extraction and sequencing platforms.
AdditiveTypical Tube ColorKey ComponentsPrimary Applications
K2EDTAPurple/LavenderDipotassium EDTA (1.8 mg/mL) (CBC, blood typing) – prevents clotting by calcium
3.2% buffered (0.109 M), 9:1 blood ratio (PT, PTT) – reversible calcium binding
Lithium GreenLithium heparin spray (e.g., 95 USP units)Plasma chemistry (electrolytes, enzymes) – inhibition without sodium bias
NaF/KOxGray (10 mg)/ (8 mg)Glucose/ inhibition
Silica Clot ActivatorRed/GoldMicronized silica particles chemistry – 30-60 min clotting acceleration
Orange/Red (RST)Thrombin-basedStat – 5 min clotting for urgent tests
No Metal AdditivesNone or minimal EDTA elements – contamination-free analysis
High CitrateBlack3.8% (0.105 M), 4:1 ratioESR – rate for

History and Development

Invention and Early Patents

The Vacutainer blood collection system was invented by Joseph J. Kleiner, a researcher from , who developed the concept in the late 1940s to address limitations in traditional syringe-based blood drawing methods. Inspired by evacuated glass tubes used by the military for blood transport during , Kleiner aimed to create a device that would streamline collection, minimize exposure to air, and reduce contamination risks for both patients and healthcare workers. His innovation centered on a vacuum-sealed glass tube system that allowed blood to flow directly into the tube upon , improving efficiency and sterility over manual aspiration techniques. Kleiner filed the initial for his "blood collecting apparatus" on August 14, 1945, which was granted as U.S. 2,460,641 on February 1, 1949. The patented design featured an evacuated sealed with a rubber stopper containing a self-sealing , paired with a double-ended needle and a reusable holder. This setup enabled multiple draws from a single without disassembling the apparatus, as the inner needle pierced the to create a closed pathway for entry driven by the tube's vacuum. The system was initially known as the "Evacutainer" before being rebranded by Becton Dickinson (), to which Kleiner later assigned the rights. Early prototypes in the mid-1940s consisted of simple glass tubes with rubber stoppers, prototyped to meet the growing demands of blood banking post-World War II. Key challenges included preserving integrity to prevent leaks during storage and transport, and ensuring sterility by avoiding air contact with the blood sample. Kleiner overcame these through the diaphragm's self-sealing mechanism, which automatically resealed after needle withdrawal, and by incorporating materials that maintained a stable without compromising the tube's seal. Initial development focused on glass for its durability and compatibility with sterilization processes, with rubber selected for its flexibility and resealability. The invention also addressed hemolysis concerns prevalent in syringe methods, where mechanical agitation often ruptured red blood cells; the gentle vacuum draw in Kleiner's design minimized forces, leading to clearer samples with reduced . By 1947, prototypes demonstrated practical viability for clinical use, paving the way for the device's assignment to and broader adoption in settings. This pre-commercial phase marked a significant shift toward standardized, safer tools.

Commercialization and Evolution

Becton Dickinson (BD) commercialized the Vacutainer collection system following Joseph Kleiner's invention, with the assigned to the company and the first tubes launched in 1949. This innovation quickly gained traction due to its advantages in reducing contamination risks and improving efficiency over traditional open collection methods. began in 1960, facilitating widespread adoption in U.S. hospitals throughout the decade as standardized draw procedures became integral to clinical laboratories. Early Vacutainer tubes were made of , but BD introduced plastic versions in 1991 to enhance safety, durability, and reduce breakage during handling and transport. This shift addressed key limitations of , making the system lighter and more cost-effective for routine use. In the late , BD further advanced safety features with the introduction of the Vacutainer blood collection needle in 1999, incorporating a one-handed activation shield to minimize needlestick injuries. The Vacutainer system expanded globally, achieving compliance with international standards such as ISO 6710 for single-use specimen containers, which ensures consistent performance and quality across borders. maintains a leading position in the vacuum blood collection tube market, alongside competitors like , driven by ongoing innovations in tube design and compatibility with diverse laboratory workflows. In recent years, Vacutainer tubes have supported advancements in by providing reliable preanalytical sample collection compatible with rapid analyzers, particularly post-2010 as POC technologies proliferated in intensive care and community settings. During the , BD Vacutainer tubes played a key role in high-volume testing, with studies confirming their suitability for accurate detection while highlighting the impact of tube type and anticoagulants on SARS-CoV-2 results.

Clinical Use and Safety

Blood Collection Procedures

Blood collection using the Vacutainer system begins with thorough preparation to ensure and specimen integrity. The phlebotomist must first verify the patient's using at least two forms of , such as name and date of birth, in the patient's presence. The site is selected, with the in the antecubital fossa preferred due to its superficial position, stability, and accessibility. The site is cleansed with an swab using a from center outward, allowing the to air dry completely to avoid or . A is applied 3-4 inches above the site, tight enough to restrict venous flow but not arterial, and should not remain in place for more than 1 minute to prevent hemoconcentration or discomfort. The patient is instructed to make a fist to engorge the veins, and materials including a 21-22 multi-sample needle attached to the Vacutainer holder, alcohol swab, , gloves, and appropriate tubes are assembled. The order of draw follows Clinical and Laboratory Standards Institute (CLSI) guidelines to minimize cross-contamination between additives in different tubes, which could alter test results. Tubes are filled sequentially starting with bottles (if required), followed by citrate (light blue top for studies), serum tubes (red or gold top), (green top), EDTA (lavender top for ), and finally tubes with other additives like (gray top). This sequence prevents carryover of additives, such as EDTA contaminating samples and causing pseudohyperkalemia. When using a , a discard tube (non-additive or ) is drawn first before the citrate tube to account for potential dilution. The venipuncture technique involves inserting the assembled 21-22 gauge needle with the Vacutainer holder at a 15-30 degree angle to the skin, bevel up, to pierce the vein's anterior wall only. Once blood flashback is observed, the first tube is firmly pushed into the holder to puncture the stopper, allowing the vacuum to draw blood automatically; subsequent tubes are inserted sequentially without withdrawing the needle. The tourniquet is released immediately after blood flow begins into the first tube to avoid prolonged stasis. Each tube is filled to its indicated volume, and upon removal, tubes containing additives are gently inverted 8-10 times end-over-end to ensure proper mixing without causing hemolysis; serum tubes require 5 inversions. Post-collection, the needle is withdrawn steadily while applying pressure to the site with sterile gauze for at least 1 minute to achieve hemostasis, followed by a bandage. Tubes are labeled immediately in the patient's presence with patient identifiers, collection date and time, and phlebotomist initials. Labeled tubes are transported upright at room temperature to the laboratory as promptly as possible, ideally within 2 hours for most specimens to maintain analyte stability. The used needle and holder are disposed of in a sharps container without recapping.

Safety Considerations and Best Practices

The (OSHA) mandates the use of safety-engineered devices for needlestick prevention under 29 CFR 1910.1030, the Bloodborne Pathogens Standard, which requires employers to provide sharps with engineered injury protections, such as needle retraction mechanisms, to minimize percutaneous injuries during blood collection. Becton Dickinson's () Vacutainer Eclipse system incorporates a retraction feature that activates a safety shield upon needle withdrawal, significantly reducing needlestick incidents; post-2000 implementation data from healthcare facilities, including a hospital, reported an 80% overall reduction in sharps injuries and complete elimination of blood collection-related needlesticks after adopting such BD safety-engineered needles. Contamination risks during Vacutainer use can lead to erroneous results, necessitating strict adherence to the of protocol—typically starting with tubes, followed by citrate, , , EDTA, and finally glycolytic inhibitor tubes—to prevent additive carryover, such as EDTA into samples that may cause by inducing platelet clumping and falsely low platelet counts. , another common issue that interferes with analyte measurements like and , is largely avoided through gentle handling techniques, including avoiding excessive agitation during tube inversion (limited to 5-8 gentle inversions for additive mixing) and using appropriately sized to prevent collapse or forceful aspiration. Vacutainers are classified as Class II medical devices by the U.S. Food and Drug Administration (FDA) under 21 CFR § 862.1675, requiring premarket notification (510(k)) clearance to ensure safety and effectiveness in blood collection, preservation, and transport. In the European Union, Vacutainer systems bear CE marking in compliance with the Medical Device Directive 93/42/EEC (transitioning to Regulation (EU) 2017/745), confirming conformity with essential health and safety requirements for in vitro diagnostic use. Phlebotomists must undergo certified training covering venipuncture, infection control, and safety protocols. For example, in California, this includes at least 40 hours of didactic and clinical instruction as required by state regulations. International bodies like the World Health Organization (WHO) provide guidelines on training content (2010). Best practices for Vacutainer use, such as those from CLSI (2020), advocate low-volume pediatric draws (e.g., using microtainer tubes limited to 0.5-2 mL to stay below 3% of total per draw) to minimize patient harm while ensuring sample adequacy. Used needles and assemblies must be disposed of immediately in puncture-resistant, leakproof sharps containers labeled as biohazards to comply with OSHA and EPA regulations, preventing secondary injuries and environmental contamination. Although early Vacutainer tubes posed breakage risks during handling or —potentially exposing users to pathogens—modern plastic iterations have largely eliminated these hazards, reducing injury potential from shattering.

References

  1. [1]
    BD Vacutainer ® Specimen Management Portfolio
    A novel device that collects lab-quality blood samples from the patient fingertip, without the need for phlebotomy. Learn more. forward-arrow.
  2. [2]
    BD Vacutainer® blood collection tubes
    BD Vacutainer ® Blood Collection Tubes support reliability, accuracy and integrity in the specimen pathway so clinicians get a quality specimen the first time.
  3. [3]
    [PDF] Procedures In Phlebotomy
    Vacutainer tubes were invented by Joseph Kleiner in 1949. Vacutainer is a registered trademark of Becton Dickinson, which manufactures and sells the tubes ...
  4. [4]
    [PDF] FY 2023 Corporate Sustainability Report | BD
    Nov 11, 2024 · While the used blood tubes cannot be cleaned and reused like medical devices made of glass or metal, the PET plastic is still highly.<|separator|>
  5. [5]
    [PDF] Vacutainer® - Cardinal Health
    2. Any BD Vacutainer® Needle Holders of the standard size may be used with 13 or 16 mm diameter tubes.Missing: structure | Show results with:structure
  6. [6]
    A Comparison of Blood Collection in Glass Versus Plastic ...
    BD glass Vacutainer, the plastic tube has other advantages. Safety is always an issue in the laboratory, and using plastic tubes will decrease the risk of ...
  7. [7]
    Materials Used In Vacutainer Tubes: Plastic, Glass, Stainless Steel ...
    These tubes are typically made from borosilicate glass, a type of glass that is resistant to thermal shock and chemical corrosion. Glass vacutainer tubes ...
  8. [8]
    Glass vs Plastic Vacutainers: A Blood Draw Battleground
    Dec 22, 2023 · Lighter and shatter-resistant, safer for handling and transport. · Lower cost and readily available. · Suitable for most routine laboratory tests.
  9. [9]
    Vacutainer Plus Plastic Serum Tubes, Silicone-Coated, with ...
    $$92.00 to $521.00 In stock $79 deliveryHemogard™ Stoppers. Safety shield designed for safer tube handling; Rubber stopper is recessed inside the plastic shield, so any drops left by a blood ...Missing: elements | Show results with:elements
  10. [10]
    Understanding the Different Sizes of Vacutainer Tubes - Needle.Tube
    There are several sizes of vacutainer tubes available in the market, with the most common ones being the 13mm x 75mm, 16mm x 100mm, and 13mm x 100mm tubes.Missing: components structure
  11. [11]
    [PDF] The BD Vacutainer® System - Henry Schein
    BD Vacutainer® tubes come in three main sizes, each with a range of different draw volumes. Other sizes are available and the offering varies from tube to tube.Missing: materials structure
  12. [12]
    BD Vacutainer® Luer Adapter - 367290
    All non-gel separator blood collection tubes, including those that contain heparin, EDTA and non-gel serum tubes can be centrifuged at ≤1300 RCF for 10 ...
  13. [13]
    [PDF] Vacutainer® - Evacuated Blood Collection System - NCBI
    INTENDED USE. BD Vacutainer® Tubes, Needles and Holders are used together as a system for the collection of venous blood. BD Vacutainer® Tubes are used to ...
  14. [14]
    US2460641A - Blood collecting apparatus - Google Patents
    US2460641A. United States. Patent. Download PDF Find Prior Art Similar. Inventor: Joseph J Kleiner; Current Assignee. The listed assignees may be inaccurate ...Missing: vacutainer | Show results with:vacutainer
  15. [15]
    [PDF] 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION
    The pressure differential caused the venous blood to flow into the tube. Once pressure is equalized, the blood flow ceases and the tube is withdrawn from the ...
  16. [16]
  17. [17]
    [PDF] Colour coding in blood collection - Sarstedt AG
    ISO 6710:2017, published in July 2017, met the desire for a worldwide standardisation of cap colours for blood collection tubes; this was incorporated in Annex ...Missing: Vacutainer standard
  18. [18]
    [PDF] H01-A5-Tubes and Additives for Venous Blood Specimen Collection
    This document is a performance standard for venous blood collection tubes and additives, including EDTA, sodium citrate, and heparin, and their materials, ...<|separator|>
  19. [19]
    (PDF) Colour coding for blood collection tube closures - ResearchGate
    Oct 18, 2014 · It should also be considered that although ISO 6710:2017 is intended to support standardisation of tube cap colours across manufacturers, ...<|separator|>
  20. [20]
    The Evolution of Evacuated Blood Collection Tubes ©2003 BD
    The first evacuated tube patent, Eva- cutainer, was invented by Joseph Kleiner and assigned to BD in 1949 [F1 and I1].3. Prior to the issuance of the patent,.
  21. [21]
    Celebrating 75 years of Evolution and Impact: BD Vacutainer ...
    May 6, 2024 · ... vacuum to draw blood from a vein into a sterile tube. The system also ... BD worked closely with health care institutions, laboratories ...
  22. [22]
    [PDF] BD Vacutainer® Tube Guide - ACL Laboratories
    NOTE: Gold Gel tubes should clot for 30 minutes before centrifugation. Red, no additive tubes should clot for 60 minutes before centrifugation. Tubes should be ...
  23. [23]
    [PDF] BD Integrated Diagnostic Solutions - Specimen Management
    RFID tag and transport box identification. Signal receiver. Adaptable to laboratory workflows. RFID Tag ... Vacutainer® SSTTM II Plus Tubes for ...Missing: aids | Show results with:aids
  24. [24]
    Order of Blood Draw Tubes and Additives - CLSI
    Mar 19, 2019 · Blood samples must be drawn by phlebotomists in a specific order to avoid cross-contamination of the sample by additives found in different collection tubes.
  25. [25]
    [PDF] BD Vacutainer® K2EDTA Blood Collection Tubes - FDA
    Tube Dimensions. (mm). 13x75, 13x100, 16x100. 13x75, 13x100, 16x100. Identical. Draw Volume. 2, 3, 4, 6, 10 mL. 2, 3, 4, 6, 10 mL. Identical. Tube Material.<|control11|><|separator|>
  26. [26]
    BD Vacutainer® Fluoride Tubes - 367925
    Tube Size, 13x100. Draw Volume, 6. Closure Type/Color, BD Hemogard™ Closure/gray. Label Type, Paper. Additive/Concentration, Sodium fluoride 15 mg, potassium ...
  27. [27]
    Thrombin-Accelerated Quick Clotting Serum Tubes - PubMed Central
    The Becton Dickinson BD vacutainer rapid serum tube (RST BD 368774) has a 5-min clotting time which is advantageous for any immediate processing in the high ...Missing: silica applications
  28. [28]
    B-D Vacutainer Combination Kit | National Museum of American ...
    Ref: Joseph J. Kleiner, “Blood Collecting Apparatus,” U.S. Patent 2,460,641 (Feb. 1, 1949). Location: Currently not on view. Object Name ...
  29. [29]
    A Brief History of Blood Collection Systems and Devices - Neoteryx
    Jan 24, 2017 · Before the modern vacuum tube, collecting blood was difficult and imprecise. DBS made it easier. Later, VAMS made blood collection easy and ...
  30. [30]
    Becton Dickinson - Headlines
    Franklin Lakes, NJ -- Tuesday, February 02, 1999 -- BD [Nyse: BDX] today announced the introduction in the United States of the new VACUTAINER® Brand ECLIPSE ...
  31. [31]
    ISO 6710:2017 - Single-use containers for human venous blood ...
    CHF 98.00 2–5 day deliveryISO 6710:2017 specifies requirements and test methods for evacuated and non-evacuated single-use venous blood specimen containers.
  32. [32]
    Vacutainer Blood Collection Tube Consumer Trends
    Rating 4.8 (1,980) Aug 3, 2025 · October 2023: BD launches a new line of safety-engineered vacutainer tubes. ... BD and Terumo lead the market in terms of market share and ...
  33. [33]
    Preanalytical conditions of point-of-care testing in the intensive care ...
    Jun 24, 2016 · The aim of this study was to assess the reliability of results provided by point-of-care analyzers according to the organization of the care units and the ...
  34. [34]
    Blood collection tube and anticoagulant influence on SARS-CoV-2 ...
    Jul 30, 2024 · SARS-CoV-2 serology can be used to evaluate the immunogenicity of participants following COVID-19 vaccinations or infection. In general, blood ...
  35. [35]
    Blood Collection Process: Venipuncture
    ROUTINE VENIPUNCTURE GUIDELINES. MATERIALS. 1. Safety Needles, 22g or less. 2. Butterfly needles. 21g or less. 3. Syringes. 4. Vacutainer tube holder.<|control11|><|separator|>
  36. [36]
    Best practices in phlebotomy - WHO Guidelines on Drawing Blood
    Anchor the vein by holding the patient's arm and placing a thumb BELOW the venepuncture site. Ask the patient to form a fist so the veins are more prominent.
  37. [37]
    Phlebotomy tutorial for medical education - WebPath
    Collect drops of blood into the collection device by gently massaging the finger. Avoid excessive pressure that may squeeze tissue fluid into the drop of blood.<|control11|><|separator|>
  38. [38]
    [PDF] Blood Collection Procedures - Patient Preparation - VCU Pathology
    Jul 1, 2018 · Prepare the Vacutainer® holder by aseptically screwing the double-end needle into the holder. Prepare the Vacutainer® tubes (observe order of ...
  39. [39]
  40. [40]
    BD Vacutainer® Eclipse™ blood collection needle
    It features a safety shield that allows for one-handed activation to cover the needle immediately upon withdrawal from the vein and confirms proper activation ...
  41. [41]
    Toronto Hospital Reduces Sharps Injuries by 80%, Eliminates Blood ...
    "BD-Canada helped TEGH successfully achieve a significant reduction in needlestick injuries by providing education, training and support to staff throughout ...
  42. [42]
    The Order of Draw during Blood Collection: A Systematic Literature ...
    Feb 7, 2021 · The most recent evidence affirms the negligible effect of the order of draw during blood collection when using the closed blood collection system.
  43. [43]
    Pseudothrombocytopenia and other conditions associated with ...
    Mar 27, 2025 · Conditions causing spurious thrombocytopenia include the following. (i) Pre-analytical errors, such as difficult venipuncture, over-/under- ...
  44. [44]
    Preventing Hemolysis in Blood Samples - Needle.Tube
    3. Gentle Handling. It is important to handle blood samples with care to prevent hemolysis. This includes avoiding excessive shaking or agitation of the sample, ...
  45. [45]
    [PDF] How to Prepare a Quality Sample: Preventing Hemolysis
    How can hemolyzed specimens be prevented? • For routine collections, use a 20-22 gauge needle. • Do not remove the needle from the vein with the vacuum tube ...
  46. [46]
    BD Receives CE Mark for Next Generation Blood Separation ...
    BD Vacutainer® Barricor™ Tube Designed to Enhance Sample Quality, Improve Laboratory Efficiency and Speed Laboratory Turnaround Time.
  47. [47]
    Phlebotomy Certificate - CDPH - CA.gov
    Jun 16, 2025 · Complete 40 hours phlebotomy practice in a clinical setting that includes performance of at least 50 venipunctures and 10 skin punctures and ...Phlebotomy Training Schools · Certified Phlebotomy... · CPT II
  48. [48]
    Performing Pediatric Phlebotomy - CLSI
    Mar 9, 2020 · The use of low-volume collection tubes is also recommended to minimize the vacuum pressure that could otherwise cause vein collapse and minimize ...<|separator|>
  49. [49]
    Best Way to Get Rid of Used Needles and Other Sharps - FDA
    Aug 10, 2023 · Step 1: Place all needles and other sharps in a sharps disposal container immediately after they have been used. This will reduce the risk of needle sticks, ...Missing: Vacutainer | Show results with:Vacutainer
  50. [50]
    [PDF] Disposal of Contaminated Needles and Blood Tube Holders ... - OSHA
    Employers must make available, closable, puncture resistant, leakproof sharps containers that are appropriately labeled and color-coded. The containers must ...Missing: Vacutainer | Show results with:Vacutainer
  51. [51]
    Hybrid Blood Collection Tubes: Combining the Best Attributes ... - NIH
    The original design of the first evacuated BCT, invented and patented by Joseph Kleiner in 1945, was an innovative breakthrough that revolutionized blood ...